Compounds > gyki 52466
Page last updated: 2024-10-28

gyki 52466 and Atherosclerotic Parkinsonism

gyki 52466 has been researched along with Atherosclerotic Parkinsonism in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stauch Slusher, B1
Rissolo, KC1
Anzilotti, KF1
Jackson, PF1

Other Studies

1 other study available for gyki 52466 and Atherosclerotic Parkinsonism

ArticleYear
Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats.
    Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 9, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Excitatory Amino Acid Antagonists; Male; Mesencephalo

1995